Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
The Pitt star took to social media to share his celebration after nabbing awards for Best Performance by an Actor in a Drama ...
Last year, it emerged that Health New Zealand used an Excel spreadsheet as its "primary data file" for managing and analysing ...
U.S. Energy Secretary Chris Wright also noted yesterday that the revenue from sales of Venezuelan oil would be used to ...
Holding announced that its neuroprotective candidate Privosegtor was granted breakthrough therapy designation by the U.S. Food and ...
Moving yourself or a loved one to a senior living facility can be challenging, but the positive results might surprise you. Jorge Argota, a 34-year-old owner of a boutique marketing company in ...
Detailed price information for Capital Clean Energy Carriers Corp (CCEC-Q) from The Globe and Mail including charting and trades.
The strategy summarises the case for change, identifies road safety targets and outlines an approach to monitoring the ...
Zacks Investment Research on MSNOpinion
Hospital industry reshaping under strain: 3 stocks worth watching
The Zacks Medical-Hospital industry faces mounting pressure from higher utilization, rising labor and supply costs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback